NNSA Awards Agreement to Establish Non-HEU-Based Production of Molybdenum-99 in US

NNSA’s Global Threat Reduction Initiative announced today the award of a cooperative agreement to further accelerate the establishment of accelerator-based technology to produce the critical medical isotope molybdenum-99 (Mo-99) in the U.S. The agreement with NorthStar Medical Radioisotopes, LLC, is important to ensuring a reliable domestic supply of Mo-99 for U.S. patients, produced without the use of highly enriched uranium.

Read more: http://1.usa.gov/WaOvpj